Changing trends in the management of Klatskin tumor

Hepato-Gastroenterology

Volumn 51, Issue 57, 2004, Pages 689-696

  Lygidakis, N J ^a,c   Singh, Gurusharan ^a   Safioleas, M ^a   Solomou, E K ^b   Grigorakos, L ^a   Vrachnos, P ^a  

^a HENRY DUNANT HOSPITAL   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c NONE   (Greece)

Author keywords

Klatskin tumor; Portal vein ligation; Portal vein resection and reconstruction

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; FOLINATE CALCIUM; IODINATED POPPYSEED OIL; MEGLUMINE DIATRIZOATE; MITOMYCIN; RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; ARTICLE; BILIARY TRACT DRAINAGE; CANCER SURGERY; CHEMOTHERAPY; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; KLATSKIN TUMOR; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PORTAL VEIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; VEIN LIGATION;

AGED; BILE DUCT NEOPLASMS; FEMALE; HEPATECTOMY; HEPATIC DUCT, COMMON; HUMANS; KLATSKIN'S TUMOR; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 2342631938     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Klatskin G: Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: an unusual tumor with distinctive clinical and pathologic features. Am J Med 1965; 38:241-256.
2. Blumgart LH: Liver resection-liver and biliary tumors. In: Blumgart LH (Ed.). Surgery of the liver and biliary tract, 2nd Edition. New York: Churchill Livingstone, 1994; pp. 1495-1538.
3. Guthrie CM, Haddock G, De Beaux AC, et al: Changing trends in the management of extrahepatic cholangiocarcinoma. Br J Surg 1993; 80:1434-1439.
4. Kuvshinoff BW, Armstrong JG, Fong Y, et al: Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995; 82:1522-1525.
5. Terblanche J, Sanders SJ, Louw JH: Prolonged palliation in carcinoma of the main hepatic duct junction. Surgery 1972; 71:720-731.
6. Liu CL, Lo CM, Lai EC, et al: Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg 1998; 133:293-296.
7. Praderi RC: Twelve years experience with transhepatic intubation. Ann Surg 1974; 179:937-940.
8. Bowling TE, Galbraith SM, Hatfield AR, et al: A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non resectable cholangiocarcinoma. Gut 1996; 39:852-855.
9. Schima W, Prokesch R, et al: Biliary wall stent endoprosthesis in malignant hilar obstruction: long term results with regard to the type of obstruction. Clin Radiol 1997; 52:213-219.
10. Jarnagin WR, Burke E, Powers C, et al: Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg 1998; 175:453-460.
11. Sullivan RC, Faris TD: Hepaticojejunostomy. Modified Longmire operation for bile duct carcinoma. Am J Surg 1967; 114:722-725.
12. Schoenthaler R, Philips TL, Castro J, et al: Carcinoma of the extrahepatic bile ducts. Ann Surg 1994; 219:267-274.
13. Nagorney DM, Donohue JH, Farnell MB, et al: Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993; 128:871-877.
14. Childs T, Hart M: Aggressive surgical therapy for Klatskin tumors. Am J Surg 1993; 165:554-557.
15. Ogura Y, Mizumoto R, Tabata M, et al: Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas. World J Surg 1993; 17:85-92.
16. Tashiro S, Tsuji T, Kanemitsu K, et al: Prolongation of survival for carcinoma at the hepatic duct confluence. Surgery 1993; 113:270-278.
17. Bhuiya MR, Nimura Y, Kamiya J, et al: Clinicopathological factors influencing survival of patients with bile duct carcinoma; multivariate analysis. World J Surg 1993; 17:653-657.
18. Baer HU, Stain SC, Dennison AR, et al: Improvements in survival by aggressive resection of hilar cholangiocarcinoma. Ann Surg 1993; 217:20-27.
19. Bismuth H, Nakache R, Diamond T: Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215:31-38.
20. Reding R, Buard JL, Lebeau G, et al: Surgical management of 552 carcinomas of the extrahepatic bile ducts. Ann Surg 1991; 213:236-241.
21. Hadis NS, Blenkharn JL, Alexander N, et al: Outcome of radical surgery for hilar cholangiocarcinoma. Surgery 1990; 107:597-604.
22. Cameron JL, Pitt HA, Zinner MJ, et al: Management of proximal cholangiocarcinoma by surgical resection and radiotherapy. Am J Surg 1990; 159:91-97.
23. Nimura T, Hayakawa N, Kamiya J, et al: Hepatic segmentectomy with caudate lobectomy for bile duct carcinoma of the hepatic hilus. World J Surg 1990; 14:535-543.
24. Tsuzuki T, Ueda M, Kuramochi S, et al: Carcinoma of the main hepatic duct junction: Indications, operative morbidity and mortality, and long term survival. Surgery 1990; 108:495-501.
25. Pinson CW, Rossi RL: Extended right hepatic lobectomy, left hepatic lobectomy and skeletonization resection for proximal bile duct cancer. World J Surg 1988; 12:52-59.
26. Bengmark S, Ekberg H, Evander A, et al: Major liver resection for hilar cholangiocarcinoma. Ann Surg 1988; 207:120-125.
27. Mizumoto R, Kawarada T, Suzuki H: Surgical treatment of hilar cholangiocarcinoma. Surg Gynecol Obstet 1986; 162:153-158.
28. Blumgart LH, Hadjis NS, Benjamin IS, et al: Surgical approaches to cholangiocarcinoma at the confluence of the hepatic ducts. Lancet 1984; 1:166-170.
29. Tsuzuki T, Ogata T, Lida S, et al: Carcinoma of the bifurcation of the hepatic ducts. Arch Surg 1983; 118:1147-1151.
30. Launois B, Campion JP, Brissot P, et al: Carcinoma of the hepatic hilus. Surgical management and the case for resection. Ann Surg 1979; 190:151-157.
31. Lygidakis NJ, Van der Heyde MN, Verbeek PC, Van Leeuwen DJ: Technical considerations for the management of primary cholangiocarcinoma of the porta hepatis. Semin Liver Dis 1990; 10(2):126-130.
32. Lygidakis NJ, Tsiliakos S, Talaat A, Matsakis G, Tepetes K: Multidisciplinary management of hepatocellular carcinoma. Hepatogastroenterology 1997; 44:268-273.
33. Lygidakis NJ, VAnder Heyde MN, Van Dongen RJAM, Kromhout JG, Tytgat GNJ, Huibregtse K: Surgical approaches for unresectable primary carcinoma of the hepatic hilus. Surg Gynecol Obstet 1988; 166:107-114.
34. Lygidakis NJ, Kosmidis P, Ziras N, Parissis J, Kyparidou E: Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma. J Interferon Cytokine Res 1995; 15(5):467-472.
35. Lygidakis NJ, Pothoulakis J, Konstantinidou AE, Spanos H: Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre and post operative locoregional immunotherapy-chemotherapy. A prospective randomized study. Anti Cancer Res 1996; 15(2):543-550.
36. Lygidakis NJ, Vlachos L, Raptis S, Rassidakis G, Balaskas C, Sgourakis G, Mourikis D, Kehagias D, Kittas C: New frontiers in liver surgery. Two stage surgery for the management of advanced metastatic liver disease. Hepatogastroenterology 1999; 46(28):2216-2228.
37. Lygidakis NJ, Sgourakis G, Valchos L, Raptis S, Safioleas M, Boura P, Kountouras J, Alamani M: Metastatic Liver disease of colorectal origin: The value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection-Results of a prospective randomized study. Hepatogastroenterology 2001; 48:1685-1691.
38. Gerhards MF, Gulik TM, de Wit LT, et al: Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma: a single centre experience. Surgery 2000; 127:395-404.
39. Neuhaus P, Jonas S, Bechstein WO, et al: Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230:808-819.
40. Klempnauer J, Ridder GJ, Wasielewski R, et al: Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997; 15:947-954.
41. Nimura T, Kamiya J, Nagino M, et al: Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 1998; 5:52-61.
42. Sakaguchi S, Nakamura S: Surgery of the portal vein in resection of the cancer of the hepatic hilus. Surgery 1986; 99:344-349.
43. Nimura T, Hayakawa N, Kamiya J, et al: Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg 1991; 78:727-731.
44. Miyazaki M, Ito H, Nakagawa K, et al: Parenchymal preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 1999; 189:575-583.
45. Nimura T, Tomoki Ebata, et al: Hepatectomy with portal vein resection for hilar cholangiocarcinoma: Audit of 52 consecutive cases. Ann Surg 2003; 238:720-727.
46. Todoroki T, Kawamoto T, Koike N, et al: Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg 2000; 87:306-313.